ACT

FEBRUARY 13/2018


Advertisment

news roundup

UPS Expands Special Commodities Program to More Countries

UPS announced a major expansion to its International Special Commodities program. Customers can ship biological substances, dangerous goods in excepted quantities, and shipments utilizing dry ice via UPS to more than 50 additional international destinations.


advertisment

Considerations for Efficient Site Contracts and Payments
Clinical trial agreement development has a tremendous impact on study start-up – integrating site-level budgets, payment terms, and Clinical Trial Management Systems set-up. By understanding the most important considerations for contract development and budget planning, you can execute a fully-integrated process that results in high-efficiency enabled contracts and payments. Download the White Paper


Medidata Offers New Data and Analytic Capabilities

Medidata takes step to offer the most complete data and analytic capabilities in clinical research, with new predictive analytics and benchmarking in Edge Study Feasibility and MEDS Perform.


advertisment

Scientific Advice with Regulators – An Essential Tool in Early Drug Development
Live Webcast- Europe: Thursday, March 29, 2018 at 3:00pm CEST, North America: Tuesday, April 17 at 11:00am EDT
Register now


TransCelerate BioPharma Sponsors Campaign to Address Need for Clinical Trial Participants

TransCelerate BioPharma Inc., has unveiled a new global campaign called "One Person Closer" designed to help increase awareness of the growing need for clinical trial participants.


advertisment

The Benefits of a Data-driven Approach to Feasibility
Live Webcast: Tuesday, March 20 at 11:00am EDT
Register now


Trial By Fire Solutions Expands its SimpleTrials Product

Trial By Fire Solutions has expanded its SimpleTrials product, the first on-demand, subscription-based clinical trial management system.


advertisment

Immuno-Gene Therapeutics in Hematological Cancers: How Science Drives Study Strategy
Live Webcast: Tuesday, February 20 at 11:00am EST
Register now

advertisment

In this edition

UPS Expands Special Commodities Program to More Countries
Revolutionizing Clinical Trials Through Real-Time Data Capture and Analytics
Expected Changes to the Vendor Landscape in 2018
Clinical Trials for Rare Diseases

advertisment


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Events

EFGCP Annual Conference 2018
Clinical Trial Budgeting & Forecasting
EU Clinical Trial Regulation Summit
ADF 2018 - Abuse Deterrent Formulations Summit
Search Upcoming Events


Advertisment

Articles

Enrollment Cycle Times Can and Should be Optimized

Case study shows that site activation is a key driver in determining patient enrollment cycle time, which can be minimized by identifying the "sweet spot" of sites to deploy for a clinical trial.


advertisment

The Rare Disease Revolution
On Demand
Learn more


Revolutionizing Clinical Trials Through Real-Time Data Capture and Analytics

This article discusses real-time data capture and analytics in clinical trials.

Blog Posts

Expected Changes to the Vendor Landscape in 2018

An industry shift has led toward more insourcing and in-house resources to run trials.


advertisment

Research Reveals a Need for Evolution in Randomization and Trial Supply Management (RTSM) Technology
On Demand
Learn more


Janssen Develops Analytical Vendor Oversight Model

Kristy Galante, Director Process and Infrastructure of External Alliances at Janssen, recently spoke about a novel vendor oversight model at ExL's 8th Clinical Quality Oversight Forum, and will expand on the model in this interview.


Oncology

Clinical Trials for Rare Diseases

This eBook will focus on advancing research, drug development, and trial management in rare diseases. Articles cover considerations from virtual trials and eCOA to the case for highly-skilled CRAs.


 

The Impact of Faster Drug Approvals on Oncology Clinical Trial Design

Due to a shifting landscape because of faster drug approvals, this article offers strategies for sponsors to design clinical trials.


Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com